Market Research Logo

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review

Aeterna Zentaris Inc (AEZS) - Financial and Strategic SWOT Analysis Review

- SWOT Analysis Review provides you an provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Aeterna Zentaris Inc (Aeterna Zentaris) is a specialty biopharmaceutical company that focuses on the development and commercialization of novel pharmaceutical therapies for the treatment of endocrine disorders and cancer. The company’s lead product, Macrilen (macimorelin), a ghrelin receptor agonist and orally-active small molecule is used for the treatment of patients with adult growth hormone deficiency (AGHD). The company’s AEZS-120 is a pipeline prospect candidate which is in discovery phase and intended for the treatment of Prostate cancer. Aeterna Zentaris has licensed Novo Nordisk A/S, to develop, manufacture, register and commercialize Macrilen in the US and Canada. The company has operations in the US, Canada, Germany and has license agreements for its products in Ireland, China, British Virgin Islands, Singapore and other countries as well. Aeterna Zentaris is headquartered in Summerville, South Carolina, the US.

Aeterna Zentaris Inc Key Recent Developments

Jun 06,2019: Aeterna Zentaris provides corporate update
May 07,2019: Aeterna Zentaris announces first quarter 2019 financial results
Mar 26,2019: Aeterna Zentaris announces fourth quarter and full-year 2018 financial and operating results
Dec 21,2018: Aeterna Zentaris settles dispute with David Dodd and Philip Theodore
Nov 06,2018: Aeterna Zentaris reports third quarter 2018 financial and operating results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Aeterna Zentaris Inc - Key Facts
Aeterna Zentaris Inc - Key Employees
Aeterna Zentaris Inc - Key Employee Biographies
Aeterna Zentaris Inc - Major Products and Services
Aeterna Zentaris Inc - History
Aeterna Zentaris Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Aeterna Zentaris Inc - Business Description
Geographical Segment: British Virgin Islands
Performance
Geographical Segment: China
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: United States
Performance
Aeterna Zentaris Inc - Corporate Strategy
Aeterna Zentaris Inc - SWOT Analysis
SWOT Analysis - Overview
Aeterna Zentaris Inc - Strengths
Aeterna Zentaris Inc - Weaknesses
Aeterna Zentaris Inc - Opportunities
Aeterna Zentaris Inc - Threats
Aeterna Zentaris Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aeterna Zentaris Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jun 06, 2019: Aeterna Zentaris provides corporate update
May 07, 2019: Aeterna Zentaris announces first quarter 2019 financial results
Mar 26, 2019: Aeterna Zentaris announces fourth quarter and full-year 2018 financial and operating results
Dec 21, 2018: Aeterna Zentaris settles dispute with David Dodd and Philip Theodore
Nov 06, 2018: Aeterna Zentaris reports third quarter 2018 financial and operating results
Sep 25, 2018: Aeterna Zentaris names Leslie Auld as Chief Financial Officer
Aug 09, 2018: Aeterna Zentaris reports second quarter 2018 financial and operating results
May 31, 2018: Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH
May 08, 2018: Aeterna Zentaris Announces Results of Annual and Special Shareholders’ Meeting
May 07, 2018: Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Aeterna Zentaris Inc, Key Facts
Aeterna Zentaris Inc, Key Employees
Aeterna Zentaris Inc, Key Employee Biographies
Aeterna Zentaris Inc, Major Products and Services
Aeterna Zentaris Inc, History
Aeterna Zentaris Inc, Subsidiaries
Aeterna Zentaris Inc, Key Competitors
Aeterna Zentaris Inc, Ratios based on current share price
Aeterna Zentaris Inc, Annual Ratios
Aeterna Zentaris Inc, Annual Ratios (Cont...1)
Aeterna Zentaris Inc, Interim Ratios
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Aeterna Zentaris Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Aeterna Zentaris Inc, Performance Chart (2014 - 2018)
Aeterna Zentaris Inc, Ratio Charts
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Aeterna Zentaris Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report